Literature DB >> 103576

Human alpha-1-antichymotrypsin: purification and properties.

J Travis, D Garner, J Bowen.   

Abstract

Human alpha-1-antichymotrypsin has been purified to homogeneity by the following sequential steps--(a) ammonium sulfate fractionation; (b) chromatography on Cibacron Blue Sepharose at pH 7.0; and (c) chromatography on SP-Sephadex C-50 at pH 5.5. The inhibitor has a molecular weight near 68,000 and contains approximately 26% carbohydrate alpha-1-Antichymotrypsin has an amino-terminal arginine and a carboxy-terminal glycine. It also has some homology with alpha-1-PI based on amino-terminal sequence analysis of both proteins. Complexes of alpha-1-antichymotrypsin with human chymotrypsin and human leukocyte cathepsin G are stable in sodium dodecyl sulfate and have molecular weights near 90,000 suggesting 1:1 complex formation on a molar basis between inhibitor and enzyme.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 103576     DOI: 10.1021/bi00619a010

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  13 in total

1.  The equine protease inhibitory system (Pi): abnormal expressions of PiF, PiL, and PiS1.

Authors:  S D Patterson; K Bell
Journal:  Biochem Genet       Date:  1986-08       Impact factor: 1.890

2.  The 1.8 A crystal structure of human cathepsin G in complex with Suc-Val-Pro-PheP-(OPh)2: a Janus-faced proteinase with two opposite specificities.

Authors:  P Hof; I Mayr; R Huber; E Korzus; J Potempa; J Travis; J C Powers; W Bode
Journal:  EMBO J       Date:  1996-10-15       Impact factor: 11.598

3.  Potential mechanism of emphysema: alpha 1-proteinase inhibitor recovered from lungs of cigarette smokers contains oxidized methionine and has decreased elastase inhibitory capacity.

Authors:  H Carp; F Miller; J R Hoidal; A Janoff
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

4.  Chromatography of plasma proteins on immobilized Cibacron Blue F3-GA. Mechanism of the molecular interaction.

Authors:  E Gianazza; P Arnaud
Journal:  Biochem J       Date:  1982-06-01       Impact factor: 3.857

5.  Enzymatic reduction of oxidized alpha-1-proteinase inhibitor restores biological activity.

Authors:  W R Abrams; G Weinbaum; L Weissbach; H Weissbach; N Brot
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

6.  DNA structures decorated with cathepsin G/secretory leukocyte proteinase inhibitor stimulate IFNI production by plasmacytoid dendritic cells.

Authors:  Joanna Skrzeczynska-Moncznik; Agnieszka Wlodarczyk; Magdalena Banas; Mateusz Kwitniewski; Katarzyna Zabieglo; Monika Kapinska-Mrowiecka; Adam Dubin; Joanna Cichy
Journal:  Am J Clin Exp Immunol       Date:  2013-06-15

7.  Immunohistochemical localization of alpha 1-antitrypsin and alpha 1-antichymotrypsin in salivary pleomorphic adenomas.

Authors:  N Murase; K Kobayashi; H Mitani; M Mori
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

8.  Cloning of the human alpha 1 antichymotrypsin gene and genetic analysis of the gene in relation to alpha 1 antitrypsin deficiency.

Authors:  G D Kelsey; D Abeliovich; C J McMahon; D Whitehouse; G Corney; S Povey; D A Hopkinson; J Wolfe; G Mieli-Vergani; A P Mowat
Journal:  J Med Genet       Date:  1988-06       Impact factor: 6.318

9.  A general method for fractionation of plasma proteins. Dye-ligand affinity chromatography on immobilized Cibacron blue F3-GA.

Authors:  E Gianazza; P Arnaud
Journal:  Biochem J       Date:  1982-01-01       Impact factor: 3.857

10.  Complement and protease inhibitors in the mucocutaneous lymph node syndrome.

Authors:  C H Rieger; T Kawasaki; Y Yanase; U Pollack
Journal:  Eur J Pediatr       Date:  1983-04       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.